tm logo
PHARMATEK LABORATORIES
Live/Registered
REGISTERED AND RENEWED

on 20 Aug 2015

Last Applicant/ Owned by

5626 Oberlin Drive

San Diego

CA

92121

Serial Number

76105400 filed on 08th Aug 2000

Registration Number

2920287 registered on 25th Jan 2005

in the Principal Register

Correspondent Address

Vanessa A. Ignacio, Esq.

Vanessa A. Ignacio, Esq.

65 Livingston Avenue

Roseland NJ 07068

Filing Basis

1. filed as use application

2. use application currently

Disclaimer

NO DATA

PHARMATEK LABORATORIES

Pharmaceutical product development that identifies compatible oral formulations for new drug candidates, applying physiochemical evaluation techniques to traditional and state of the art pharmaceutical excipients using a compatability matrix

Classification Information


Class [042]
Computer & Software Services & Scientific Services


Pharmaceutical product development that identifies compatible oral formulations for new drug candidates, applying physiochemical evaluation techniques to traditional and state of the art pharmaceutical excipients using a compatability matrix


First Use Date in General

19th Apr 1999

First Use Date in Commerce

19th Apr 1999

Mark Details


Serial Number

No 76105400

Mark Type

No Service Mark

Attorney Docket Number

No 20332-708

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
25th Jan 2024COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
22nd May 2019ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
07th Apr 2017TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
07th Apr 2017ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
22nd Feb 2017ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
23rd Nov 2016ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
20th Aug 2015CASE ASSIGNED TO POST REGISTRATION PARALEGAL
20th Aug 2015REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
20th Aug 2015REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
20th Aug 2015NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED